ES2150589T3 - Polisacaridos con un alto contenido de acido iduronico. - Google Patents

Polisacaridos con un alto contenido de acido iduronico.

Info

Publication number
ES2150589T3
ES2150589T3 ES95937026T ES95937026T ES2150589T3 ES 2150589 T3 ES2150589 T3 ES 2150589T3 ES 95937026 T ES95937026 T ES 95937026T ES 95937026 T ES95937026 T ES 95937026T ES 2150589 T3 ES2150589 T3 ES 2150589T3
Authority
ES
Spain
Prior art keywords
polysaccharides
high content
iduronic acid
sulfation
ndesactilation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95937026T
Other languages
English (en)
Inventor
Giorgio Zoppetti
Pasqua Oreste
Giovanni Cipolletti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inalco SpA
Original Assignee
Inalco SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11369805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2150589(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Inalco SpA filed Critical Inalco SpA
Application granted granted Critical
Publication of ES2150589T3 publication Critical patent/ES2150589T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE POLISACARIDOS QUE TIENEN UN CONTENIDO ELEVADO DE ACIDO IDURONICO QUE COMPRENDE: NDESACETILACION DEL POLISACARIDO K5 DE E.COLI O DEL SULFATO DE HEPARANO U O-DESULFURACION DE SULFATO DE HEPARINA O DE HEPARANO; B) N-SULFATACION DEL PRODUCTO OBTENIDO DEL PASO A); C) EPIMERIZACION EN PRESENCIA DE LA ENZIMA DE EPIMERASA C5; D) SULFATACION DE AL MENOS ALGUNOS GRUPOS DE HIDROXIDO LIBRE, EN DONDE EL PASO C) SE LLEVA A CABO EN UN MEDIO DE REACCION CONSTITUIDO POR UNA SOLUCION CLASICA DE TAMPON FORMADA POR HEPES, CLORURO POTASICO, EDTA Y TRITON X-100 A LOS QUE SE AÑADE UN ADITIVO ADECUADO.
ES95937026T 1994-11-04 1995-10-30 Polisacaridos con un alto contenido de acido iduronico. Expired - Lifetime ES2150589T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI942240A IT1271057B (it) 1994-11-04 1994-11-04 Polisaccaridi aventi un elevato contenuto di acido iduronico

Publications (1)

Publication Number Publication Date
ES2150589T3 true ES2150589T3 (es) 2000-12-01

Family

ID=11369805

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95937026T Expired - Lifetime ES2150589T3 (es) 1994-11-04 1995-10-30 Polisacaridos con un alto contenido de acido iduronico.

Country Status (13)

Country Link
US (1) US5958899A (es)
EP (1) EP0789777B1 (es)
JP (1) JP3640259B2 (es)
CN (1) CN1094977C (es)
AT (1) ATE195348T1 (es)
AU (1) AU3926195A (es)
CA (1) CA2204366A1 (es)
DE (1) DE69518333T2 (es)
DK (1) DK0789777T3 (es)
ES (1) ES2150589T3 (es)
IT (1) IT1271057B (es)
PT (1) PT789777E (es)
WO (1) WO1996014425A1 (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1282994B1 (it) * 1996-05-10 1998-04-03 Inalco Spa Derivati del polisaccaride k5 aventi elevata attivita' anticoagulante
SE9701454D0 (sv) 1997-04-18 1997-04-18 Ulf Lindahl new DNA sequences and a process for enzyme manufacture
US20080108110A1 (en) * 1998-04-02 2008-05-08 Deangelis Paul L Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US8088604B2 (en) 1998-04-02 2012-01-03 The Board Of Regents Of The University Of Oklahoma Production of defined monodisperse heparosan polymers and unnatural polymers with polysaccharide synthases
US7223571B2 (en) * 1998-04-02 2007-05-29 The Board Of Regents Of The Universtiy Of Oklahoma Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
US20060188966A1 (en) * 1998-04-02 2006-08-24 Deangelis Paul L Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
US20040197868A1 (en) * 2001-05-08 2004-10-07 Deangelis Paul L. Heparin/heparosan synthase from P. multocida, soluble and single action catalysts thereof and methods of making and using same
CN1098354C (zh) * 1998-11-12 2003-01-08 武汉大学 双酶催化法合成1－β－D－呋喃核糖苷－1，2，4－三氮唑－3－甲酰胺
US6608042B2 (en) 2000-03-28 2003-08-19 Aventis Pharma, S.A. Pharmaceutical compositions containing oligosaccharides, the novel oligosaccharides and preparation thereof
US20020062019A1 (en) 2000-03-30 2002-05-23 Pasqua Oreste Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
IT1318432B1 (it) * 2000-03-30 2003-08-25 Inalco Spa Glicosaminoglicani derivati dal polisaccaride k5 aventi elevataattivita' anticoagulante ed antitrombotica e processo per la loro
US8227449B2 (en) 2000-03-30 2012-07-24 Glycores 2000 S.R.L. Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation
AU2002217174B2 (en) 2000-12-08 2006-06-22 Biotie Therapies Corp. Glucuronyl C5-epimerase, DNA encoding the same and uses thereof
ITMI20032498A1 (it) 2003-12-17 2005-06-18 Pasqua Anna Oreste Polisaccaridi antitrombotici a basso peso molecolare e
ITMI20010397A1 (it) * 2001-02-27 2002-08-27 Giorgio Zoppetti Derivati altamente n,o-solfatati del polisaccaride k5 e loro preparazione
WO2002089742A2 (en) * 2001-05-08 2002-11-14 The Board Of Regents Of The University Of Oklahoma Heparin/heparosan synthase and methods of making and using same
US8580290B2 (en) * 2001-05-08 2013-11-12 The Board Of Regents Of The University Of Oklahoma Heparosan-based biomaterials and coatings and methods of production and use thereof
AU2003225724A1 (en) * 2002-03-11 2003-09-29 Momenta Pharmaceuticals, Inc. Analysis of sulfated polysaccharides
CN1675250B (zh) * 2002-06-18 2012-11-14 格利考斯2000有限公司 硫酸盐化程度非常高的k5多糖的差向异构衍生物
US8513407B2 (en) * 2002-06-18 2013-08-20 Glycores 2000 S.R.L. Process for the preparation of N-acyl-(epi)K5-amine-O-sulfate-derivatives and products thus obtained
US20120253029A1 (en) 2002-06-18 2012-10-04 Pasqua Anna Oreste Process for the preparation of highly o-sulfated epimerized derivatives of k5 polysaccharide and intermediates therein
GB0216861D0 (en) * 2002-07-19 2002-08-28 Univ Birmingham Saccharide libraries
US20040171819A1 (en) 2002-10-10 2004-09-02 Aventis Pharma S.A. Mixtures of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
ITMI20031618A1 (it) * 2003-08-06 2005-02-07 Inalco Spa Derivati polisaccaridici dotati di alta attivita'
FI20065035A (fi) * 2006-01-19 2007-07-20 Polysackaridforskning I Uppsal Olennaisesti puhdas entsyymi
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
WO2009014715A2 (en) * 2007-07-23 2009-01-29 The University Of North Carolina At Chapel Hill Enzymatic synthesis of sulfated polysaccharides without iduronic acid residues
US9925209B2 (en) 2008-03-19 2018-03-27 The Board Of Regents Of The University Of Oklahoma Heparosan-polypeptide and heparosan-polynucleotide drug conjugates and methods of making and using same
US9687559B2 (en) * 2008-03-19 2017-06-27 The Board Of Regents Of The University Of Oklahoma Heparosan polymers and methods of making and using same for the enhancement of therapeutics
CN101591401A (zh) * 2009-02-27 2009-12-02 江南大学 一种制备高活性低分子量肝素的方法
ES2817779T3 (es) * 2010-01-19 2021-04-08 Momenta Pharmaceuticals Inc Evaluación de preparaciones de heparina
US11203772B2 (en) 2010-12-23 2021-12-21 The University Of North Carolina At Chapel Hill Chemoenzymatic synthesis of structurally homogeneous ultra-low molecular weight heparins
US9068957B2 (en) 2011-02-21 2015-06-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
WO2013149161A1 (en) 2012-03-30 2013-10-03 Deangelis Paul L High molecular weight heparosan polymers and methods of production and use thereof
WO2014204929A2 (en) 2013-06-17 2014-12-24 The University Of North Carolina At Chapel Hill Reversible heparin molecules and methods of making and using the same
WO2016159296A1 (ja) * 2015-03-31 2016-10-06 生化学工業株式会社 グリコサミノグリカンの硫酸化方法
WO2018165656A1 (en) 2017-03-10 2018-09-13 The University Of North Carolina At Chapel Hill Short-acting heparin-based anticoagulant compounds and methods
US11993627B2 (en) 2017-07-03 2024-05-28 The University Of North Carolina At Chapel Hill Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides
CN111601603A (zh) 2017-11-03 2020-08-28 北卡罗来纳大学查珀尔希尔分校 具有抗炎活性的硫酸化寡糖
CN108486187A (zh) * 2018-02-02 2018-09-04 南京微构医药科技有限公司 一种艾杜糖醛酸的制备工艺
CN112437667B (zh) 2018-06-20 2024-05-28 北卡罗来纳大学查珀尔希尔分校 细胞保护方法和组合物
CN110577559B (zh) * 2019-08-19 2023-02-17 江西科技师范大学 α-L-艾杜糖醛酸酶测定用荧光糖苷酶底物的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2286193A (en) * 1991-03-28 1995-08-09 Italfarmaco Spa Anticoagulants and processes for preparing such

Also Published As

Publication number Publication date
ATE195348T1 (de) 2000-08-15
JPH10508204A (ja) 1998-08-18
EP0789777B1 (en) 2000-08-09
CN1094977C (zh) 2002-11-27
DE69518333D1 (en) 2000-09-14
DK0789777T3 (da) 2000-11-06
JP3640259B2 (ja) 2005-04-20
CA2204366A1 (en) 1996-05-17
DE69518333T2 (de) 2001-02-22
CN1162339A (zh) 1997-10-15
AU3926195A (en) 1996-05-31
US5958899A (en) 1999-09-28
ITMI942240A1 (it) 1996-05-04
PT789777E (pt) 2001-01-31
EP0789777A1 (en) 1997-08-20
ITMI942240A0 (it) 1994-11-04
IT1271057B (it) 1997-05-26
WO1996014425A1 (en) 1996-05-17

Similar Documents

Publication Publication Date Title
ES2150589T3 (es) Polisacaridos con un alto contenido de acido iduronico.
AU3026597A (en) Derivatives of k5 polysaccharide having high anticoagulant activity
ATE94554T1 (de) Oligosaccharide, verwendbar als haarwuchsmittel.
ATE497035T1 (de) Lyozellfaser und zusammensetzungen zu ihrer herstellung
PA8584201A1 (es) Mezcla de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
ES8302776A1 (es) "un procedimiento para preparar un b-1,3-glucano de alto peso molecular".
PT82198B (pt) Processo de producao de sulfato de heparano e sulfato de dermatano, naturais, em forma substancialmente pura e de composicoes farmaceuticas que os contem
Hopwood et al. Diagnosis of Sanfilippo type A syndrome by estimation of sulfamidase activity using a radiolabelled tetrasaccharide substrate
AU8371782A (en) Polysaccharide anti-thromboticum
JPS63191801A (ja) 多糖類の制御された解重合方法
Linker et al. The hyaluronidase of the leech: an endoglucuronidase
PT986580E (pt) Misturas de oligossacarideos com actividade antitrombotica
Jaurand et al. Biologically active heparin-like fragments with a “non-glycosamino” glycan structure. Part 1: a pentasaccharide containing a 3-O-methyl iduronic acid unit.
Pinhal et al. Antithrombotic agents stimulate the synthesis and modify the sulfation pattern of a heparan sulfate proteoglycan from endothelial cells
NZ331585A (en) Process for reducing the viscosity of a polysaccharide with hydrogen peroxide and an acylated polysaccharide as activator
Linker Structure of heparan sulphate oligosaccharides and their degradation by exo-enzymes
Levy et al. Glycosaminoglycan Biosynthesis in Arterial Wall: Sulfation of Heparan Sulfate in Cell Membrane of Aortic Media‐Intima
KR950002789A (ko) 개선된 저점도의 고농도 황산바륨 조영제 및 그의 제조방법
BR8602609A (pt) Processo para a preparacao de uma solucao aquosa de um heteropolissacarideo,solucao aquosa de um heteropolissacarideo,e,processo para utilizar uma solucao aquosa de um heteropolissacarideo
JPS6487695A (en) Additive for long-lifetime and high-concentration coal-water slurry
ES2154601A1 (es) Procedimiento para la obtencion de fluoruro sodico.
JPS57163477A (en) Preservative for food and drink and preserving method thereof (1)
ES2001748A6 (es) Un procedimiento para la produccion del heteropolisacarido s-184.
Kamada et al. Structure of heparan sulfate from rat kidney and liver
ES2071742T3 (es) Proceso para la escision de acido uronico delta4-insaturado a partir de glicosaminoglicanos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 789777

Country of ref document: ES